Zentalis PharmaceuticalsL Valuation

ZNTL Stock  USD 17.15  0.68  3.81%   
What is the current enterprise value of Zentalis PharmaceuticalsL? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Zentalis PharmaceuticalsL, is its stock price multiplied by the total number of shares outstanding, calculating Zentalis PharmaceuticalsL's enterprise value requires a different approach. It uses Zentalis PharmaceuticalsL's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Enterprise Value is expected to rise to about 1.5 B this year, although the value of Free Cash Flow will most likely fall to (170.7 M).
Zentalis PharmaceuticalsL maintains a prevalent Real Value of $25.08 per share. The last-minute price of the company is $17.15. At this time, the company appears to be undervalued. Our model calculates the value of Zentalis PharmaceuticalsL from examining the company fundamentals such as Shares Owned by Insiders of 4.18 %, return on asset of (0.29) %, and Current Valuation of 720.73 M as well as analyzing its technical indicators and Probability Of Bankruptcy. In general, we encourage picking up undervalued securities and discarding overvalued securities since, at some point, asset prices and their ongoing real values will grow together.
Zentalis PharmaceuticalsL Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Zentalis PharmaceuticalsL's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

Zentalis Most Recent Valuation Data

Fiscal Year End
Enterprise Value
720.7 M
Accounts Payable
60.1 M
Today 17.15
Please note that Zentalis PharmaceuticalsL's price fluctuation is not too volatile at this time. Calculation of the real value of Zentalis PharmaceuticalsL is based on 3 months time horizon. Increasing Zentalis PharmaceuticalsL's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Zentalis PharmaceuticalsLlc is useful when determining the fair value of the Zentalis stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Zentalis PharmaceuticalsL. Since Zentalis PharmaceuticalsL is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Zentalis Stock. However, Zentalis PharmaceuticalsL's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Real Value
Estimating the potential upside or downside of Zentalis PharmaceuticalsLlc helps investors to forecast how Zentalis stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Zentalis PharmaceuticalsL more accurately as focusing exclusively on Zentalis PharmaceuticalsL's fundamentals will not take into account other important factors:
Estimates (6)
LowProjected EPSHigh
LowEstimated ValueHigh
10 Analysts
LowTarget PriceHigh
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Zentalis PharmaceuticalsL's intrinsic value based on its ongoing forecasts of Zentalis PharmaceuticalsL's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Zentalis PharmaceuticalsL's closest peers. When choosing an evaluation method for Zentalis PharmaceuticalsL, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Zentalis PharmaceuticalsL Investments

414.9 Million

Zentalis Valuation Drivers Correlation

Many accounts on the financial statements of Zentalis PharmaceuticalsL are highly interrelated and sometimes correlated. Consequently, when conducting Zentalis's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Zentalis
Click cells to compare fundamentals

Zentalis Valuation Trend

Knowing Zentalis PharmaceuticalsL's actual value is paramount for traders to make sound investment determinations. Zentalis PharmaceuticalsL's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Zentalis PharmaceuticalsL's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Zentalis PharmaceuticalsL's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Zentalis Market Cap

Zentalis PharmaceuticalsLlc is rated first in market capitalization category among related companies. Market capitalization of Health Care industry is at this time estimated at about 1.91 Billion. Zentalis PharmaceuticalsL totals roughly 1.02 Billion in market capitalization claiming about 53% of equities under Health Care industry.
Capitalization  Revenue  Workforce  Valuation  Total debt

Zentalis PharmaceuticalsL Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Zentalis PharmaceuticalsL's current stock value. Our valuation model uses many indicators to compare Zentalis PharmaceuticalsL value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Zentalis PharmaceuticalsL competition to find correlations between indicators driving Zentalis PharmaceuticalsL's intrinsic value. More Info.
Zentalis PharmaceuticalsLlc is rated second in beta category among related companies. It is rated first in net asset category among related companies making up about  289,127,754  of Net Asset per Beta. The value of Average Assets is estimated to slide to about 446.2 M. The Tangible Asset Value is projected to slide to about 452 M. Comparative valuation analysis is a catch-all model that can be used if you cannot value Zentalis PharmaceuticalsL by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Zentalis PharmaceuticalsL's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Zentalis PharmaceuticalsL's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Zentalis PharmaceuticalsL's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Zentalis PharmaceuticalsL and how it compares across the competition.

About Zentalis PharmaceuticalsL Valuation

The stock valuation mechanism determines the current worth of Zentalis PharmaceuticalsLlc on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Zentalis PharmaceuticalsLlc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Zentalis PharmaceuticalsL based exclusively on its fundamental and basic technical indicators. By analyzing Zentalis PharmaceuticalsL's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Zentalis PharmaceuticalsL's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Zentalis PharmaceuticalsL. We calculate exposure to Zentalis PharmaceuticalsL's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Zentalis PharmaceuticalsL's related companies.
Fiscal Year End
Full Time Employees
Service Category
Last ReportedProjected for 2023
Gross Profit12.6 K12.5 K

Zentalis PharmaceuticalsL Quarterly Enterprise Value

1.1 Billion

8 Steps to conduct Zentalis PharmaceuticalsL's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Zentalis PharmaceuticalsL's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Zentalis PharmaceuticalsL's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Zentalis PharmaceuticalsL's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Zentalis PharmaceuticalsL's revenue streams: Identify Zentalis PharmaceuticalsL's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Zentalis PharmaceuticalsL's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Zentalis PharmaceuticalsL's growth potential: Evaluate Zentalis PharmaceuticalsL's management, business model, and growth potential.
  • Determine Zentalis PharmaceuticalsL's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Zentalis PharmaceuticalsL's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Zentalis PharmaceuticalsL Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Zentalis PharmaceuticalsL does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding59.3 M
Retained Earnings-596.4 M
Retained Earnings Total Equity-596.4 M

Zentalis PharmaceuticalsL Current Valuation Indicators

Valuation refers to the process of determining the present value of Zentalis PharmaceuticalsLlc and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Zentalis we look at many different elements of the entity such as Zentalis's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Zentalis PharmaceuticalsL's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Zentalis PharmaceuticalsL's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Zentalis PharmaceuticalsL, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Zentalis PharmaceuticalsL's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Zentalis PharmaceuticalsL's worth.
Check out Your Current Watchlist. For more information on how to buy Zentalis Stock please use our How to buy in Zentalis Stock guide. You can also try Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for analysis

When running Zentalis PharmaceuticalsL price analysis, check to measure Zentalis PharmaceuticalsL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zentalis PharmaceuticalsL is operating at the current time. Most of Zentalis PharmaceuticalsL's value examination focuses on studying past and present price action to predict the probability of Zentalis PharmaceuticalsL's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Zentalis PharmaceuticalsL's price. Additionally, you may evaluate how the addition of Zentalis PharmaceuticalsL to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Bond Directory
Find actively traded corporate debentures issued by US companies
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Is Zentalis PharmaceuticalsL's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zentalis PharmaceuticalsL. If investors know Zentalis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zentalis PharmaceuticalsL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Return On Assets
Return On Equity
The market value of Zentalis PharmaceuticalsL is measured differently than its book value, which is the value of Zentalis that is recorded on the company's balance sheet. Investors also form their own opinion of Zentalis PharmaceuticalsL's value that differs from its market value or its book value, called intrinsic value, which is Zentalis PharmaceuticalsL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zentalis PharmaceuticalsL's market value can be influenced by many factors that don't directly affect Zentalis PharmaceuticalsL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zentalis PharmaceuticalsL's value and its price as these two are different measures arrived at by different means. Investors typically determine Zentalis PharmaceuticalsL value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zentalis PharmaceuticalsL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.